Looking for a stable dividend stock that offers strong fundamentals and growth reliability in the health care sector? This large-cap medical devices company may be just the one to watch. With a 50+ year streak of uninterrupted dividend increases and a robust 3-year dividend compound annual growth rate (CAGR) of 7%, this stock has proven its dedication to shareholder returns. While its forward yield may not be the highest, its combination of dividend safety, low returns risk, and consistent growth makes it an attractive option for quality dividend investors focused on long-term wealth building.
Operating in the heart of the health care sector, this company is riding the wave of strong industry tailwinds—especially in areas like digital health, chronic disease management, and emerging markets expansion. Its diverse business model spans diagnostics, medical devices, nutrition, and pharmaceuticals, providing resilience against sector volatility. Recent performance highlights include double-digit growth in its medical technology segment and expanding penetration in high-demand international markets. While headwinds like foreign exchange pressures and evolving tax regulations pose some risks, its strong financial footing—including a conservative 0.6x net leverage ratio—positions it well to navigate these challenges.
Want to understand how this stock continues to earn its place in the Quality Dividends Portfolio? Dive into the full article to see how it balances growth and safety, and why its dividend reliability sets it apart in today’s market.
